FIELD: medicine.
SUBSTANCE: intravesical installations are performed with preliminary bladder mucosa exposure to a laser. The laser action is carried out by emission of a high-energy YAG-Nd (yttrium-alumogranate with neodymium) laser, conducting point coagulation of the mucosa for 2 seconds per point, at 8-12 points.
EFFECT: increased effectiveness of chronic cystitis treatment due to coagulation of the mucosa coated with biofilms, to improve antibacterial substance penetration to the infectious agent.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CHRONIC CYSTITIS IN CHILDREN | 2013 |
|
RU2524769C1 |
| METHOD FOR INTEGRATED TREATMENT OF CHRONIC BACTERIAL RECURRENT CYSTITIS IN FEMALES AT AGGRAVATION STAGE | 2015 |
|
RU2593889C1 |
| AGENT FOR TREATING CHRONIC INFLAMMATORY DISEASES OF URETHRA AND BLADDER | 2015 |
|
RU2602954C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC RECURRENT BACTERIAL CYSTITIS | 2023 |
|
RU2820135C1 |
| METHOD FOR TREATING BLADDER TUBERCULOSIS | 2018 |
|
RU2702607C1 |
| METHOD OF TREATING AND PREVENTING URINATION DISORDERS | 2019 |
|
RU2708524C1 |
| METHOD OF ASSESSING STATE OF MICROCIRCULATION IN FOCUS OF URINARY BLADDER LEUKOPLAKIA IN WOMEN | 2011 |
|
RU2476153C2 |
| METHOD FOR SURGICAL TREATMENT OF STAGE 4 BLADDER TUBERCULOSIS | 2020 |
|
RU2759324C1 |
| METHOD OF TREATING INTERSTITIAL CYSTITIS USING MEDICINAL COMPOSITIONS | 2023 |
|
RU2824705C1 |
| PREVENTIVE METHOD OF POST-CITTAL CYSTITIS | 2017 |
|
RU2648443C1 |
